Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Algerian Journal of ...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2019
License: CC BY
Data sources: Datacite
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
ZENODO
Article . 2019
License: CC BY
Data sources: ZENODO
versions View all 2 versions
addClaim

This Research product is the result of merged Research products in OpenAIRE.

You have already added 0 works in your ORCID record related to the merged Research product.

in silico screening of some commercially available alkaloids against angiotensin converting enzyme using lamarckian genetic algorithm

Authors: Arumugam Madeswaran;

in silico screening of some commercially available alkaloids against angiotensin converting enzyme using lamarckian genetic algorithm

Abstract

Alkaloids are the dynamic components that may show an essential part in preventing the hypertension. Captopril, a known angiotensin converting enzyme inhibitor was considered as the standard. An in silico screening study was performed to detect the inhibitory potential of the alkaloids against angiotensin converting enzyme by using the Autodock 4.2 software. The alkaloids ajmaline, atropine, caffeine and emetine were selected for the present study. The results revealed that all the selected alkaloids exhibited binding energy ranging between -9.75 kcal/mol to -4.98 kcal/mol when compared with the standard (-5.38 kcal/mol). Inhibition constant (77.38 nM to 225.41 µM) and Intermolecular energy (-11.84 kcal/mol to -6.17 kcal/mol) of the alkaloids also concur with the binding energy. Hence, these alkaloids can be further scrutinized for in vivo studies and thereby it may act as potential chemical entities for the prevention and treatment of hypertension.

Keywords

Inhibition constant, Alkaloids, Intermolecular Energy, Binding energy, Angiotensin converting enzyme

Powered by OpenAIRE graph
Found an issue? Give us feedback